Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NICE Satmetrix is a leading provider of customer experience management (CEM) software and is widely recognized as the co-developer of the Net Promoter Score (NPS) methodology. The company's flagship product, NICE Satmetrix NPX, is a comprehensive cloud-based platform designed to help organizations capture, analyze, and act on customer feedback to drive loyalty and business growth. While the company serves a broad range of sectors including healthcare, financial services, and technology, its primary focus is on enterprise software and data analytics rather than drug development or clinical research. Since its acquisition by NICE in 2017, the company's capabilities have been integrated into the broader NICE CXone ecosystem to enhance customer journey optimization and predictive analytics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NICE Satmetrix.